Product Name: ACTA1(21-30)
Product Number: PE-01AQE95
| Size: | 200 µg | Price: | 32.00 | |
| 1 mg | $US | 64.00 | ||
| 5 mg | 140.00 |
Peptide Name: ACTA1(21-30)
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: AGFAGDDAPR
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 976.2 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: AGFAGDDAPR
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 976.2 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Scientific Background: It is seen when bovine muscle actin is degraded in the presence of caspase 3. It is peptides that results from the degradation.
References
[1] Carlos Hernán Herrera-Mende. 2010. Muscle Actin degradation by the action of Caspase 3.
[1] Carlos Hernán Herrera-Mende. 2010. Muscle Actin degradation by the action of Caspase 3.
© Kinexus Bioinformatics Corporation 2017